Missing data

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 5, Issue SUPPL. 1, 2004, Pages 48-51

  Thompson, John L P ^a   Levy, Gilberto ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ALTEPLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CREATINE; GABAPENTIN; PLACEBO; RILUZOLE; TOPIRAMATE; WARFARIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; DATA ANALYSIS; FOLLOW UP; FUNCTIONAL ASSESSMENT; GOOD CLINICAL PRACTICE; HUMAN; MEDICAL DOCUMENTATION; MORTALITY; NONBIOLOGICAL MODEL; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZATION; RATING SCALE; SENSITIVITY ANALYSIS; SURVIVAL; TREATMENT OUTCOME; VALIDATION PROCESS; CONTROLLED CLINICAL TRIAL; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS; STATISTICS;

AMYOTROPHIC LATERAL SCLEROSIS; DATA INTERPRETATION, STATISTICAL; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 6444225325     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/17434470410019753     Document Type: Article

References (15)

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis [comment]. New England Journal of Medicine 1991; 325: 445-453.
2. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis [comment]. JAMA 1995; 273: 1421-1428.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke [comment]. New England Journal of Medicine 1995; 333: 1581-1587.
4. Stroke Prevention in Atrial Fibrillation. III Randomised clinical trial. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation [comment]. Lancet 1996; 348: 633-638.
5. Mohr JP, Thompson JL, Lazar RM et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke [comment]. New England Journal of Medicine 2001; 345: 1444-1451.
6. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group [comment]. New England Journal of Medicine 1994; 330: 585-591.
7. The BDNF Study Group (Phase III). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.
8. Miller RG, Moore DH, Gelinas DF et al. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 843-848.
9. Desnuelle C, Dib M, Garrel C, Favier A, ALS riluzoletocopherol Study Group. A double-blind, placebo controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 2001; 2: 9-18.
10. Groeneveld JG, Veldink JH, van der Tweel I et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Annals of Neurology 2003; 53: 437-445.
11. Cudkowicz ME, Shefner JM, Schoenfeld DA et al. A randomized, placebo controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology 2003; 61: 456-464.
12. McDermott MP, Rowland LP. ALS defeats gabapentin: reflections on another failed treatment [comment]. Neurology 2001; 56: 826-827.
13. Levin B. Issues in clinical trials: statistical issues. Amyotrophic Lateral Sclerosis & Other Motor Neuron Disorders 2004; 5(suppl 1): 43-45.
14. Thompson JLP, Levin B, Sciacca RR, Tilley BC, Mohr JP, Sacco RL. Statistical Considerations in the WARSS Collaboration. Paper presented at the 27th International Stroke Conference of the American Stroke Association, San Antonio, Texas, February 2002.
15. Cedarbaum JM, Stambler N, Malta E et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences 1999; 169: 13-21.